BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22020421)

  • 41. Association of MMP2-1306C/T and TIMP2G-418C polymorphisms in retinal vein occlusion.
    Ortak H; Demir S; Ateş O; Söğüt E; Alim S; Benli I
    Exp Eye Res; 2013 Aug; 113():151-5. PubMed ID: 23791966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.
    Zhou Y; Yu C; Miao X; Wang Y; Tan W; Sun T; Zhang X; Xiong P; Lin D
    Carcinogenesis; 2005 Jun; 26(6):1117-21. PubMed ID: 15731163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation between matrix metalloproteinase-2 polymorphisms and first and recurrent atherosclerotic ischemic stroke events: a case-control study.
    Li Y; Ouyang QR; Li J; Chen XR; Li LL; Xu L; Yu M
    J Int Med Res; 2021 Jun; 49(6):3000605211022967. PubMed ID: 34159826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
    Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
    Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Matrix metalloproteinase-2 promoter variability in psoriasis.
    Vasku V; Bienertova Vasku J; Slonková V; Kanková K; Vasku A
    Arch Dermatol Res; 2009 Jul; 301(6):467-73. PubMed ID: 19360430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphisms in MMP-2 and TIMP-2 in Turkish patients with prostate cancer.
    Yaykaşli KO; Kayikçi MA; Yamak N; Soğuktaş H; Düzenli S; Arslan AO; Metın A; Kaya E; Hatıpoğlu ÖF
    Turk J Med Sci; 2014; 44(5):839-43. PubMed ID: 25539555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Matrix Metalloproteinases 2 and 9 and Tissue Inhibitor of Metalloproteinase 2 Gene Polymorphisms on Allograft Rejection in Pediatric Renal Transplant Recipients.
    Akad Dincer S; Sahin FI; Terzi YK; Gulleroglu K; Baskin E; Haberal M
    Exp Clin Transplant; 2023 Apr; 21(4):333-337. PubMed ID: 32799785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.
    Alakus H; Afriani N; Warnecke-Eberz U; Bollschweiler E; Fetzner U; Drebber U; Metzger R; Hölscher AH; Mönig SP
    World J Surg; 2010 Dec; 34(12):2853-9. PubMed ID: 20730428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
    Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
    Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
    Banday MZ; Sameer AS
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
    [No Abstract]   [Full Text] [Related]  

  • 52. Functional matrix metalloproteinase (MMP)-9 genetic variants modify the effects of hemodialysis on circulating MMP-9 levels.
    Marson BP; Lacchini R; Belo V; Mattos SG; da Costa BP; Poli-de-Figueiredo CE; Tanus-Santos JE
    Clin Chim Acta; 2012 Dec; 414():46-51. PubMed ID: 23010359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Matrix metalloproteinase-2, -9, and -12 gene polymorphisms in generalized aggressive periodontitis.
    Gürkan A; Emingil G; Saygan BH; Atilla G; Cinarcik S; Köse T; Berdeli A
    J Periodontol; 2007 Dec; 78(12):2338-47. PubMed ID: 18052707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
    Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
    Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A common matrix metalloproteinase (MMP)-2 polymorphism affects plasma MMP-2 levels in subjects environmentally exposed to mercury.
    Jacob-Ferreira AL; Lacchini R; Gerlach RF; Passos CJ; Barbosa F; Tanus-Santos JE
    Sci Total Environ; 2011 Sep; 409(20):4242-6. PubMed ID: 21794897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
    Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
    J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymorphisms in the Promoters of the MMP-2 and TIMP-2 Genes Are Associated with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population.
    Chen YC; Ho WM; Lee YS; Chen HW; Chen CM
    PLoS One; 2015; 10(11):e0142482. PubMed ID: 26551785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The protective role of the -1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection.
    Singh N; Hussain S; Sharma U; Suri V; Nijhawan R; Bharadwaj M; Sobti RC
    Tumour Biol; 2016 Apr; 37(4):5295-303. PubMed ID: 26561467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of MMP-2(-1306 C/T) and TIMP-2(-418G/C) Polymorphism in Chinese Han Patients with Acne Vulgaris.
    Gao R; Yu H; Zhao Q; Wang S; Bai B
    Biomed Res Int; 2019; 2019():2364581. PubMed ID: 31032338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Matrix Metalloproteinases (MMP-2,-3,-9) Gene Polymorphisms in Cases of Benign Vocal Fold Lesions and Laryngeal Carcinoma.
    Liutkevicius V; Lesauskaite V; Liutkeviciene R; Vaiciulis P; Uloza V
    In Vivo; 2020; 34(1):267-274. PubMed ID: 31882488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.